WuXi Biologics got hit again today. Even though brokerage firms are still shouting about target prices and positive earnings expectations, the market just isn't cooperating. Such a steep drop in one go is a bit hard to take. It feels like the market has a love-hate relationship with pharmaceutical stocks right now, with news always lagging three steps behind the price action. Just hold on, I'm already numb to it anyway.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
